View Older Stories View More Recent Stories

May 11, 2026 07:02AM AIML appoints cardiac electrophysiology expert to medical advisory board
May 11, 2026 07:00AM AIML Appoints Dr. Martin Green to Medical Advisory Board and Issue Options
Apr 24, 2026 07:51PM AI/ML Innovations Announces Completion of Share Issuance
Apr 17, 2026 08:00PM AI/ML Innovations Announces Completion of Share Issuance
Mar 31, 2026 07:00AM Neural Cloud signs reseller deal with European cardiac monitoring platform
Mar 31, 2026 07:00AM Neural Cloud Signs Reseller Agreement with European Digital Cardiac Monitoring Platform
Mar 27, 2026 05:00PM AIML closes first tranche of private placement raising $950,000
Mar 27, 2026 05:00PM AI/ML Innovations Inc. Announces Closing of First Tranche of Private Placement to Raise $950,000
Mar 25, 2026 07:00AM AIML Subsidiary NeuralCloud Enters Research Services Agreement with Baker Heart and Diabetes Institute to Support AI-Driven ECG Analysis
Mar 12, 2026 07:31PM AI/ML Innovations proposes $3 million convertible debenture offering
Mar 12, 2026 07:30PM AI/ML Innovations Inc. Announces Proposed Private Placement of Convertible Debentures
Feb 24, 2026 07:30AM Neural Cloud Enters Distribution Agreement with Intelimed to Expand into Latin America
Feb 12, 2026 07:00AM AIML Subsidiary NeuralCloud Signs Non-Binding Agreement with Movesense to Pilot AI-Powered ECG and Holter Reporting
Feb 10, 2026 07:00AM Neural Cloud Retains Commission Wolf to Accelerate U.S. Commercial Expansion
Jan 28, 2026 07:00AM AIML appoints cardiologist Dr. Paul Dorian to lead medical advisory board
Jan 28, 2026 07:00AM AIML Appoints Dr. Paul Dorian as Medical Innovation Architect and Head of the Medical Advisory Board
Jan 8, 2026 07:00AM AIML subsidiary NeuralCloud Solutions Inc., Signs Non-Binding Commercial Term Sheet with Lakeshore Cardiology to Deploy CardioYield(TM) for AI-Powered Holter Analysis
Jan 7, 2026 07:02AM AIML appoints Erik Suokas as chief operating officer
Jan 7, 2026 07:00AM AI/ML Appoints Erik Suokas as Chief Operating Officer to Accelerate Commercial Execution and Operational Scale
Dec 30, 2025 07:31AM AIML concludes consulting agreement, names CEO as president
Dec 30, 2025 07:30AM AIML Announces the Conclusion of Consulting Agreement and Leadership Transition for President & Chief Commercial Officer
Dec 16, 2025 07:30AM Join AIML's Live Shareholder Update with Chairman & CEO Paul Duffy
Dec 9, 2025 07:30AM AIML subsidiary NeuralCloud Solutions Signs Commercial Term Sheet with Culminate H Labs to Deploy MaxYield(TM) and Insight360(TM) into INTRINSICA's DNA-Guided Biofeedback Wellness Ecosystem
Dec 2, 2025 07:30AM AIML Subsidiary NeuralCloud Enters Pilot with Cornerstone Physiotherapy to Deploy MaxYield(TM) and Insight360(TM) for Elite Athlete Cardiac Performance Testing
Nov 26, 2025 07:30AM AIML Subsidiary NeuralCloud Signs Commercial Term Sheet With Equimetrics To Deploy Maxyield(TM) And Cardioyield(TM) Across Equine Cardiac Monitoring Platforms
Nov 24, 2025 07:30AM AI/ML Subsidiary Neural Cloud Begins Pilot at SickKids to Advance AI-Enabled Pediatric Cardiac Care
Nov 11, 2025 07:30AM AI/ML Innovations Inc. Announces Grant of U.S. Patent Protecting Core ECG Signal-Processing Architecture
Nov 4, 2025 07:30AM AIML Subsidiary NeuralCloud Solutions Engages Lonacas Consultants to Lead Regulatory Submission for CardioYield(TM) in Jamaica
Oct 21, 2025 07:30AM AIML Subsidiary NeuralCloud Solutions Commencing Pilot with Canadian Cardiology Clinic to Advance AI-Powered ECG Reporting
Oct 15, 2025 07:30AM AIML Subsidiary NeuralCloud Solutions and Heartdent Center Ltd. Launch Pilot Project to Advance Cardiac Care in Jamaica
Oct 7, 2025 07:00AM AIML Subsidiary NeuralCloud Solutions and Toronto Heart Centre Launch a Pilot Program to Test AI-Powered Holter ECG Reporting
Sep 30, 2025 07:00AM AIML and BC Brain Wellness Program Launch Pilot to Explore the Heart–Brain Connection
Sep 22, 2025 08:15PM AIML raises $2.13 million in oversubscribed private placement
Sep 22, 2025 08:15PM AIML Announces Closing of Oversubscribed Private Placement
Sep 4, 2025 08:26AM AIML plans private placement to raise up to $1.55 million
Sep 4, 2025 08:25AM AIML Announces Proposed Private Placement
Aug 21, 2025 05:35PM AIML Announces SEDAR Filing
Aug 8, 2025 05:30PM AIML Innovations Closes Quantum Sciences Ltd. Restructuring
Jun 10, 2025 07:00AM AIML Strengthens IP Portfolio with Provisional Patents for AI Driven ECG Signal Processing
May 22, 2025 07:00AM AI/ML Establishes Innovation Committee, Appoints Dr. Drew Dundas as Chair
May 15, 2025 07:00AM AIML Hits Key Regulatory Benchmark with 510(k) Filing for MaxYield(TM) Signal Enhancement Platform
May 5, 2025 07:00AM AIML Innovations Appoints Political Strategist and Public Affairs Leader, Michael Diamond, to Board of Directors
Apr 25, 2025 05:30PM AIML Innovations Announces Departure of Tim Daniels from Board of Directors
Apr 25, 2025 05:00PM AIML Optimizes Quantum Sciences Acquisition to Drive Growth & Strategic Focus
Apr 22, 2025 07:00AM AIML Innovations Appoints Jared Adelstein to Board of Directors
Apr 15, 2025 05:30PM AIML Announces Closing of Oversubscribed Private Placement
Apr 7, 2025 08:00AM AIML Updates Terms of Proposed Private Placement Announced
Apr 4, 2025 07:00PM AIML Announces Proposed Private Placement
Mar 21, 2025 05:15PM AIML Continues to Streamline for the Future and Moves Beyond Tech2Heal
Mar 14, 2025 07:00AM AIML Aligns Leadership for Growth and Shareholder Value Creation
View More Recent Stories View Older Stories